Company record
MACLEODS PHARMA USA, INC
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about MACLEODS PHARMA USA, INC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 4 | Class II | MACLEODS PHARMA USA, INC Drug |
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma U… Failed Dissolution Specifications. |
| Apr 1 | Class II | MACLEODS PHARMA USA, INC Drug |
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 333… Subpotent Drug |